|
Teva Pulls Wellbutrin Generic After FDA Study Finds Efficacy Issues
Teva and Impax have ceased shipping their 300-mg generic of GlaxoSmithKline’s antidepressant Wellbutrin XL following an FDA determination that the drug is not therapeutically equivalent to its branded counterpart.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives